We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Maharaj will also serve as a member of company’s board of directors. Maharaj, who most recently served as president and CEO of Arizant, will replace Philip Ankeny who
Known as IPNT in the global market, the company will employ eProtex solutions in its Korean market as it lays the groundwork for a global expansion. InnoPNT provides
IRIS is a manufacturer of automated in-vitro diagnostics systems and consumables for use in hospitals and commercial laboratories worldwide, and a provider of personalized diagnostics testing services through
VeriPsych is a molecular diagnostic tool designed to complement the healthcare provider’s clinical impression. VeriPsych, based on the simultaneous measurement of 51 different protein and hormone biomarkers with
Aridol is a single-use, indirect test that is easy-to-administer, requires minimal preparation time and only a 15% reduction in lung function from baseline, Pharmaxis said. Aridol is used
Verisens PSA is an in-vitro diagnostic assay for the high-sensitivity detection and quantification of prostate specific antigen (PSA), developed in collaboration with the International Institute for Nanotechnology at
Moreau brings 26 years of diverse marketing, sales, business development, funding, investor relations, client relations, communications and operations management experience to Miraculins, having held senior executive positions in
The sam5 is a biosensor utilising Surface Acoustic Wave technology for the label-free detection of real-time binding and structural events. Using a bimodal measurement technique, the platform is
UF1 increases the speed of DNA amplification by up to ten-fold, opening up opportunities for the use of PCR in Point-of-Care diagnosis, BJS Biotechnologies said. According to BJS,
The grant was awarded to Maven through the federal stimulus package initiative for Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN). The target